Analysis of milrinone in plasma using solid-phase extraction and high-performance liquid chromatography. 1986

C J Oddie, and G P Jackman, and A Bobik

UI MeSH Term Description Entries
D008297 Male Males
D011728 Pyridones Pyridine derivatives with one or more keto groups on the ring. Pyridinones
D002316 Cardiotonic Agents Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). Cardiac Stimulant,Cardiac Stimulants,Cardioprotective Agent,Cardioprotective Agents,Cardiotonic,Cardiotonic Agent,Cardiotonic Drug,Inotropic Agents, Positive Cardiac,Myocardial Stimulant,Myocardial Stimulants,Cardiotonic Drugs,Cardiotonics,Agent, Cardioprotective,Agent, Cardiotonic,Drug, Cardiotonic,Stimulant, Cardiac,Stimulant, Myocardial
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D020105 Milrinone A positive inotropic cardiotonic agent with vasodilator properties. It inhibits cAMP phosphodiesterase type 3 activity in myocardium and vascular smooth muscle. Milrinone is a derivative of amrinone and has 20-30 times the inotropic potency of amrinone. Corotrop,Corotrope,Milrinone Lactate,Primacor,Win-47203,Lactate, Milrinone,Win 47203,Win47203

Related Publications

C J Oddie, and G P Jackman, and A Bobik
April 1994, Therapeutic drug monitoring,
C J Oddie, and G P Jackman, and A Bobik
January 2004, Journal of pharmaceutical and biomedical analysis,
C J Oddie, and G P Jackman, and A Bobik
November 1997, Journal of chromatography. B, Biomedical sciences and applications,
C J Oddie, and G P Jackman, and A Bobik
September 2005, Journal of pharmaceutical and biomedical analysis,
C J Oddie, and G P Jackman, and A Bobik
May 1999, Journal of pharmaceutical and biomedical analysis,
C J Oddie, and G P Jackman, and A Bobik
August 1998, Therapeutic drug monitoring,
C J Oddie, and G P Jackman, and A Bobik
April 2001, Journal of pharmaceutical and biomedical analysis,
C J Oddie, and G P Jackman, and A Bobik
June 2010, Environmental monitoring and assessment,
Copied contents to your clipboard!